Cargando…

Clinical evaluation of heart failure patients: what good are biomarkers bringing us?

Detalles Bibliográficos
Autor principal:	de Boer, R. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bohn Stafleu van Loghum 2014
Materias:	Editorial Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931850/ https://www.ncbi.nlm.nih.gov/pubmed/24482189 http://dx.doi.org/10.1007/s12471-014-0520-5

Ejemplares similares

Predictive tools in psychosis: what is ‘good enough’?
por: Seyedsalehi, Aida, et al.
Publicado: (2023)

Key challenges in bringing CRISPR-mediated somatic cell therapy into the clinic
por: Nicol, Dianne, et al.
Publicado: (2017)

Empagliflozin and the Prevention of Heart Failure: Will Reverse Translation Lead to New Paradigms for the Treatment of Heart Failure?
por: Mann, Douglas L., et al.
Publicado: (2017)

Will better evidence on clinical utility bring about greater use of (genetic) tests?
por: Hyde, Chris
Publicado: (2021)

Heart rate in heart failure with mid-range ejection fraction
por: Yılmaz, Mehmet Birhan
Publicado: (2019)

The Role of Macrophages in Nonischemic Heart Failure
por: Chen, Bijun, et al.
Publicado: (2018)

A Growth Tonic for Heart Failure?
por: Bishopric, Nanette H.
Publicado: (2016)

Bringing orthogeriatric care for elderly patients with hip fractures to Asia
por: Ho, Sean Wei Loong, et al.
Publicado: (2022)

What is Keeping us from Producing Good Research?
por: Shyam, Ashok
Publicado: (2018)

Mentorship: The Bond that Brings Us Together
por: Dunbar, Gary L.
Publicado: (2007)

Promoting Health Equity in Heart Failure Amid a Pandemic
por: DeFilippis, Ersilia M., et al.
Publicado: (2021)

Bringing nuclear materials discovery and qualification into the 21(st) century
por: Aguiar, Jeffery A., et al.
Publicado: (2020)

Reconsidering Renal Sympathetic Denervation for Heart Failure
por: Tang, W.H. Wilson, et al.
Publicado: (2017)

Brain-derived neurotrophic factor in heart failure
por: Yılmaz, Mehmet Birhan
Publicado: (2019)

Oxytocin: A New Therapeutic for Heart Failure?
por: Habecker, Beth A.
Publicado: (2020)

Abnormal heart rate recovery in patients with heart failure: an important target for exercise training treatment
por: Dimopoulos, Stavros
Publicado: (2015)

Bringing research directly to families in the era of COVID-19
por: Balevic, Stephen J., et al.
Publicado: (2020)

War in Ukraine and the challenges it brings to the Polish healthcare system
por: Kardas, Przemysław, et al.
Publicado: (2022)

Cardiometabolic Heart Failure and HFpEF: Still Chasing Unicorns
por: Sharp, Thomas E., et al.
Publicado: (2019)

The case of philanthropy: bringing scientists and philanthropic donors together, for good
por: Flatto, Olivia Tournay
Publicado: (2015)

Cell Therapy for Heart Failure With Preserved Ejection Fraction
por: Borlaug, Barry A., et al.
Publicado: (2016)

Metabolic Coupling as a Therapeutic Strategy for Heart Failure
por: Young, Martin E.
Publicado: (2019)

Does nitric oxide mediate the effects of ivabradine in patients with heart failure?
por: Mączewski, Michał
Publicado: (2018)

Role of ischemia-modified albumin in patients with acute decompensated heart failure
por: Pan, Defeng, et al.
Publicado: (2016)

Fine Tuning Adenylyl Cyclase as a (Gene) Therapy for Heart Failure
por: Port, J. David, et al.
Publicado: (2016)

Pulmonary hypertension in the changing landscape of congenital heart disease: Global differences and a possible driver of end-stage heart failure
por: Van De Bruaene, A., et al.
Publicado: (2016)

Heart Failure With Preserved Ejection Fraction in Women: New Clues to Causes and Treatment
por: Barton, Matthias, et al.
Publicado: (2020)

Updates in heart failure: what last year brought to us
por: Dinatolo, Elisabetta, et al.
Publicado: (2018)

To implant or not to implant?: That is the unsolved question concerning heart failure patients with non-LBBB
por: Zarse, M., et al.
Publicado: (2015)

Beyond lipid lowering: pleiotropic effects of statins in heart failure
por: Swenne, C. A.
Publicado: (2013)

Targeting Mitochondrial Function in Heart Failure: Makes Sense But Will it Work?
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2019)

Modulation of Glucagon Signaling: A Metabolic Approach for Heart Failure?
por: Pocai, Alessandro
Publicado: (2019)

COVID-19 pneumonia: what has CT taught us?
por: Lee, Elaine Y P, et al.
Publicado: (2020)

Economic evaluations in occupational health: what brings the best bang for the buck?
por: van Dongen, Johanna M, et al.
Publicado: (2022)

We need to bring R0 < 1 to treat cancer too
por: Srikrishna, Devabhaktuni, et al.
Publicado: (2021)

Coronary sinus dilatation as a sign of right ventricular dysfunction in patients with heart failure
por: Park, Yong Hyun
Publicado: (2015)

Unraveling the Mechanisms by Which Calpain Inhibition Prevents Heart Failure Development
por: Wehrens, Xander H.T.
Publicado: (2018)

Heart failure guidelines implementation: Lifting barriers using registries and networks
por: Keramida, Kalliopi, et al.
Publicado: (2020)

Understanding Heart Failure With Preserved Ejection Fraction in a Diabetic Way
por: Li, Haobo, et al.
Publicado: (2021)

The Hippo in the Clinic: An Ancient Signaling Pathway That Regulates Growth and Development Confronts a Modern Pandemic of Obesity, Diabetes, and Heart Failure
por: Gottlieb, Sheldon H.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8r7lblo8p7aig3aumdudtshupc